Colorectal Cancer
News and reporting on colorectal cancer.
Guardant Health's Shield Colorectal Cancer Blood Test Garners CMS Advanced Diagnostic Status
The test will be reimbursed at the price of $1,495 for Medicare patients during the initial nine-month ADLT period starting on April 1.
Exact Sciences Solidifies MRD and Multi-Cancer Screening Plans as Q4 Revenues Rise 10 Percent
Premium
Growth was mainly driven by an increase in colorectal cancer screening revenue, while precision oncology testing income was flat year over year.
The company analyzed MRD status in samples from a prior failed study, showing a significant benefit from the drug for ctDNA-positive patients.
Guardant Health Reveal Assay Gets Additional Medicare Coverage for CRC Surveillance Testing
The test was previously covered for use in colorectal cancer patients in the early postsurgical setting only.
Mass General Brigham Becomes Latest US Health System to Adopt Pretreatment DPYD Testing
The change in policy at the health system follows the death of a DPD deficient patient and comes during a period of intense competition among Boston hospitals.
Oct 29, 2024